- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BRAFV600 mutation
Total 3249 results
-
Pierre Fabre MedicamentRecruitingMetastatic Melanoma | Melanoma (Skin) | BRAF V600 MutationPortugal
-
Grupo Español Multidisciplinar de MelanomaCompleted
-
University of UtahWithdrawn
-
PfizerTerminatedBrain MetastasesUnited States, Belgium, Australia, Argentina, Italy
-
Hoffmann-La RocheTerminatedAdvanced BRAFV600 Wild-type MelanomaUnited States, Korea, Republic of, Australia, Belgium, France, Russian Federation, Italy, Netherlands, Spain, United Kingdom, Brazil, Poland, Germany, Greece, Hungary
-
Array BioPharmaCompletedMetastatic Colorectal CancerUnited States, Australia, Belgium, Canada, France, Israel, Italy, Netherlands, Singapore, Spain
-
PfizerTerminatedSolid Tumor | Hematologic MalignanciesUnited States
-
UNICANCERMerck Sharp & Dohme LLC; Pierre Fabre Medicament; European Association of Dermato...RecruitingBrain Metastases | Malignant Melanoma | BRAF V600 MutationFrance
-
University of Heidelberg Medical CenterGerman Cancer Research Center; University Hospital Heidelberg; Array BioPharma; Coordinating Centre for Clinical Trials HeidelbergActive, not recruitingRelapsed or Refractory Multiple Myeloma | Patients With BRAFV600 E or BRAFV600K MutationGermany
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Melanoma | Stage IV MelanomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.WithdrawnMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterArray BioPharmaCompleted
-
Hoffmann-La RocheCompletedMetastatic MelanomaFrance, Italy, Spain, Brazil, Latvia, Germany, Hungary, Switzerland
-
PfizerActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Netherlands, Korea, Republic of, Italy
-
Hoffmann-La RocheWithdrawn
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | Malignant Glioma | Anaplastic AstrocytomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsRussian Federation, Korea, Republic of, Israel, South Africa, Belarus
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
CCTU- Cancer ThemePierre Fabre MedicamentNot yet recruitingMelanoma | CancerUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Oxford; National Institute for Health Research, United Kingdom; Oxford University Hospitals NHS TrustCompleted
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Universitair Ziekenhuis BrusselCompletedStage IV Melanoma | Stage III MelanomaBelgium
-
Genentech, Inc.Completed
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsKorea, Republic of, Brazil, United States, Canada, Cyprus
-
Grupo Español Multidisciplinar de MelanomaRoche Farma, S.A; Pivotal S.L.Completed
-
GlaxoSmithKlinePfizerCompleted
-
Hoffmann-La RocheActive, not recruitingMelanomaUnited States, Korea, Republic of, United Kingdom, Australia, France, Belgium, Italy, Portugal, Spain, Brazil, Canada, Russian Federation, Germany, New Zealand, Israel, Poland, Greece, Austria, Hungary, Netherlands
-
Fondazione Melanoma OnlusWithdrawn
-
Intergruppo Melanoma ItalianoActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Recurrent Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
CelgeneTerminatedNeoplasm MetastasisUnited States, Australia
-
Azienda Ospedaliero-Universitaria di ModenaRecruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingEarly-stage Triple-negative Breast Cancer With BRCA1/2 MutationsChina
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Radboud University Medical CenterNot yet recruitingPeritoneal Carcinoma | Ovarian Carcinoma | Serous Tubal Intraepithelial Carcinoma | BRCA Mutation
-
Pauls Stradins Clinical University HospitalRecruiting
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
Tyligand Bioscience (Shanghai) LimitedRecruitingMalignant NeoplasmUnited States
-
Jacobio Pharmaceuticals Co., Ltd.Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdvanced KRAS G12D Mutant Solid TumorsChina
-
Washington University School of MedicineAlzheimer's Association; Eisai Inc.Not yet recruitingDementia | Alzheimer's Disease | Alzheimer's Disease, FamilialUnited States, Australia, United Kingdom
-
Zhejiang Cancer HospitalRecruitingHER2 Gene Mutation | Bile Duct Adenocarcinoma Non-ResectableChina
-
MedSIRStemline Therapeutics, Inc.Not yet recruitingAdvanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
-
Acerand Therapeutics (Shanghai) LimitedRecruitingBreast Cancer | Ovarian Cancer | Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation | Solid Tumor, AdultChina
-
Centro di Riferimento Oncologico - AvianoRecruitingNon Small Cell Lung Cancer Metastatic | ALK Gene MutationItaly
-
Shanghai JMT-Bio Inc.Not yet recruiting
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
AstraZenecaNot yet recruitingNeoplasms | Respiratory Tract Diseases | Lung Diseases | Neoplasms by Site | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial NeoplasmsChina